Public Policy
The company will first use the patent to combine the Apple Watch with Apple's new augmented reality headset Apple Vision Pro for closed loop AI-enabled treatment.
The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.
Alberta Spreafico, managing director of digital health and innovation at Healthware, shares how the report can guide companies' go-to-market strategies for entering the European market.
The company was also the first to receive emergency use authorization for its home COVID-19 test in 2021.
The company's Precision DL speeds up screening time, enhances the image quality of PET/CT scans and improves small lesion detection.
The company's iPredict System allows providers to detect age-related macular degeneration in the clinical setting.
HIMSS23
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.
HIMSS23
Lawrence Voyten, HIMSS board member and national advocacy chair, details how HIMSS chapter leaders can proactively support health equity and interoperability with their local governments.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.
The company's ANNE One platform allows for wireless monitoring of neonates and infants' skin and body temperature, heart and respiratory rates, and more.